BioLine RX Ltd - ADR (BLRX) has gained 1.65% Monday In Premarket Trading

BioLine RX Ltd - ADR (BLRX) is higher by Monday morning, with the stock rising 1.65% in pre-market trading to 1.85. BLRX's short-term technical score of 65 indicates that the stock has traded more bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, BLRX ranks higher than 86% of stocks. BioLine RX Ltd - ADR has fallen 9.90% over the past month, closing at $2.45 on September 4. During this period of time, the stock fell as low as $1.66 and as high as $2.53. BLRX has an average analyst recommendation of Strong Buy. The company has an average price target of $14.00.

BLRX has an Overall Score of 79. Find out what this means to you and get the rest of the rankings on BLRX!

See Full BLRX Report

BioLine RX Ltd - ADR has a Long-Term Technical rank of 97. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 3% of the market scoring higher. In the Biotechnology industry which is number 136 by this metric, BLRX ranks better than 136% of stocks.

Important Dates for Investors in BLRX:

-BioLine RX Ltd - ADR is set to release earnings on 2023-11-21. Over the last 12 months, the company has reported EPS of $-0.03. -We do not have a set dividend date for BioLine RX Ltd - ADR at this time. Click Here To Get The Full Report on BioLine RX Ltd - ADR (BLRX)